Reboli (anidulafungin)
2007
Anidulafungin versus Fluconazole for Invasive Candidiasis
In 245 patients with invasive candidiasis, anidulafungin was superior to fluconazole for global response at end of intravenous therapy.
Result
- Absolute difference
- 15.4 points
The absolute difference is derived from the event rates.
Also reported: Superiority of the echinocandin.
- Subtopic
- Candidaemia
- Design
- Double-blind RCT
- Relevance
- Important: one of several pillars.
- Source
- Reboli AC, et al. N Engl J Med. 2007;356(24):2472-2482.doi 10.1056/NEJMoa066906
Discussion & critique
Established echinocandins as first-line therapy for candidaemia. Step-down to fluconazole only in stable patients with susceptible isolates.